Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation-Reference-Cited by-同舟云学术

Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation

Published:2024-03 Issue: Volume:192 Page:110088
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Sanguineti Giuseppe,Pavarini Maddalena,Munoz Fernando,Magli Alessandro,Cante Domenico,Garibaldi Elisabetta,Gebbia Andrea,Noris Chiorda Barbara,Girelli Giuseppe,Villa Elisa,Faiella Adriana,Magdalena Waskiewicz Justyna,Avuzzi Barbara,Pastorino Alice,Moretti Eugenia,Rago Luciana,Statuto Teodora,Gatti Marco,Rancati Tiziana,Valdagni Riccardo,Luigi Vavassori Vittorio,Gisella Di Muzio Nadia,Fiorino Claudio,Cozzarini Cesare

Publisher

Elsevier BV

Reference41 articles.

1. ”Pelvic radiation disease”: New understanding and new solutions for a new disease in the era of cancer survivorship;Andreyev;Scand J Gastroenterol,2011

2. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international multicentre, randomised phase 3 trial;Pollack;Lancet,2022

3. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localized prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial;Roach;Lancet Oncol,2018

4. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Update of the long-term survival results of the GETUG-01 randomized study;Pommier;Int J Radiat Oncol Biol Phys,2016

5. Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): Outcomes from phase III randomized controlled trial;Murthy;J Clin Oncol,2021